Restoring FAS expression by reversing FAS promoter methylation: A novel approach to CTCL therapy

被引：0
|
作者：
Wu, J. [1 ,2 ]
Wood, G. S. [1 ,2 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] VAMC, Madison, WI USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
173
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL
    Zoi-Toli, O
    Vermeer, MH
    De Vries, E
    Van Beek, P
    Meijer, CJLM
    Willemze, R
    BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) : 313 - 319
  • [2] FAS-ligand (FASL) expression in cutaneous T-cell lymphoma (CTCL) is regulated by promoter methylation and can be derepressed by methotrexate (MTX)
    Nihal, M.
    Wu, J.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S75 - S75
  • [3] Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation
    Wu, Jianqiang
    Nihal, Minakshi
    Siddiqui, Jawed
    Vonderheid, Eric C.
    Wood, Gary S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (05) : 1165 - 1173
  • [4] Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma
    Butler L.M.
    Dobrovic A.
    Bianco T.
    Cowled P.A.
    British Journal of Cancer, 2000, 82 (1) : 131 - 135
  • [5] Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma
    Butler, LM
    Dobrovic, A
    Bianco, T
    Cowled, PA
    BRITISH JOURNAL OF CANCER, 2000, 82 (01) : 131 - 135
  • [6] Romidepsin and PUVA therapy in refractory advanced stage CTCL is associated with remission and increased cell death and Fas expression
    Chan, D. V.
    Szabo, D.
    Frederickson, J.
    Ziegler, R.
    Kartono, F.
    Porcu, P.
    Wong, H. K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S187 - S187
  • [7] Low FAS/CD95 expression in CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS up-regulation
    Wu, I.
    Nihal, M.
    Siddiqui, I.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S26 - S26
  • [8] Fas/FasL interaction: A novel immune therapy approach with immobilized biologicals
    Scholz, M
    Cinatl, J
    MEDICINAL RESEARCH REVIEWS, 2005, 25 (03) : 331 - 342
  • [9] The act of expression of Fas, Fas ligand in chronic hepatitis during interferon therapy.
    Yoneyama, K
    Komatsu, M
    Goto, T
    Ooshima, S
    Watanabe, S
    HEPATOLOGY, 2000, 32 (04) : 496A - 496A
  • [10] Transcriptional regulation of FAS expression by CTCL cells determines sensitivity to FAS-ligand mediated apoptosis and can be altered by enhancer region mutations
    Wu, J.
    Siddiqui, J.
    Nihal, M.
    Wood, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S21 - S21
12345